Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Matt Hancock

AstraZeneca AZ

AZ’s COVID-19 vaccine shows promise in younger and older adults

Company said vaccine produces similar immune response in younger and older adults

- PMLiVE

Both AZ and J&J set to resume US COVID-19 vaccine trials

Both companies paused their trials after separate participant illness events

- PMLiVE

Vaccine developers call on FDA to offer clarity on COVID-19 trials

Comments from J&J and Pfizer made before FDA advisory committee meeting yesterday

- PMLiVE

Moderna completes enrolment of phase 3 COVID-19 vaccine trial

Late-stage study hits 30,000 participant target

COVID-19 – a catalyst for technology adoption in clinical trials

As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good

Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients

Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to...

Impetus Digital

Roles of Neuroscience & AI in Solving Complex Healthcare Challenges

Dr. Phillip Alvelda, CEO and Co-Founder of Brainworks, discusses all things artificial intelligence and machine learning. We also explore the concepts of whole-brain AI systems and ambient biometrics, and how AI-enhanced vital...

Impetus Digital

- PMLiVE

Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses

New developments for COVID-19 treatments and vaccines

- PMLiVE

AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death

Reports indicate that the death occurred in the placebo group

- PMLiVE

Independent consultant will review Lilly’s COVID-19 plant issues

COVID-19 antibody trial was paused last week due to safety issue

AstraZeneca AZ

AZ’s US-based COVID-19 vaccine trial could restart this week

Sources briefed on the matter disclosed possible timeline to Reuters

How will COVID-19 affect uptake of vaccinations against other diseases?

Will COVID-19 help or hinder the quest to increase uptake of other vaccinations?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links